Court Tosses Suit Over Lundbeck's Purchase Of Two Drugs Used In Premature Infants

Federal judge finds NeoProfen and Indocin IV are not in the same product market; FTC and Minnesota filed suit after Lundbeck raised the price of Indocin, then the only approved drug, by 1,300%.